Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Equities

Equities

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Earnings
  • Equities
  • Guidance
  • News

USA Compression Q4 Revenue Surpasses Market Predictions, Eyes Bright 2024 Amid Tight Compression Market

By Akanksha Bakshi
February 13, 12:21 PM
USA Compression Partners, LP reported 18.4% revenue growth in Q4 2023, with EPS of $0.02 and net income including a $10.5 million loss. 2024 outlook includes expected growth and improved financials.

USAC

Read More
2 minute read
  • Biotech
  • Equities
  • General
  • Health Care
  • Movers
  • News
  • Trading Ideas

What’s Going With Hereditary Angioedema-Focused KalVista Pharmaceuticals Stock On Tuesday?

By Vandana Singh
February 13, 12:02 PM
Results from KalVista Pharmaceuticals' Phase 3 KONFIDENT trial. Sebetralstat, an oral on-demand therapy, shows efficacy for hereditary angioedema.

KALV

Read More
1 minute read
  • Earnings
  • Equities
  • Guidance
  • Movers
  • News

Why WK Kellogg Shares Are Rising Tuesday

By Nabaparna Bhattacharya
February 13, 11:50 AM
WK Kellogg shares surge as Q4 net sales beat estimates, despite a decline, with increased price/mix and adjusted EBITDA growth, prompting raised adjusted EBITDA guidance for 2024.

KLG

Read More
1 minute read
  • Earnings
  • Equities
  • General
  • Guidance
  • Large Cap
  • Movers
  • News

What’s Going On With Lattice Semiconductor Shares Today?

By Lekha Gupta
February 13, 11:25 AM
Lattice Semiconductor reported mixed Q4 results, revenue missed consensus, EPS beat. Despite near-term cyclical industry headwinds, the company said it continues to be well positioned for the long-term with a rapidly expanding product portfolio and strong customer momentum.

LSCC

Read More
1 minute read
  • Earnings
  • Equities
  • General
  • Guidance
  • Markets
  • Movers
  • News

What’s Going On With Restaurant Brands Shares After Q4 Results?

By Nabaparna Bhattacharya
February 13, 11:02 AM
Restaurant Brands shares decline despite surpassing Q4 expectations, with solid revenue, EPS, and strong system-wide sales growth.

QSR

Read More
2 minute read
  • Dividends
  • Earnings
  • Equities
  • Guidance
  • Large Cap
  • Movers
  • News

What’s Going On With Beer Maker Molson Coors Stock Today?

By Lekha Gupta
February 13, 10:41 AM
Molson Coors saw strong Q4 earnings, beating estimates and issuing positive 2024 guidance. Net sales increased 6.1% driven by favorable price and sales mix, favorable foreign currency impacts and higher financial volumes.

TAP

Read More
2 minute read
  • Analyst Color
  • Broad U.S. Equity ETFs
  • Economics
  • Equities
  • ETFs
  • General
  • Large Cap
  • Macro Economic Events
  • Markets
  • News
  • Sector ETFs
  • Tech
  • Top Stories

Magnificent 7 Is ‘The Most Crowded Trade’ Among Institutional Investors, With Two-Thirds Dismissing Recession Fears

By Neil Dennis
February 13, 10:30 AM
Global investors bullish on equities as economy expected to avoid recession; investing in Magnificent Seven stocks like Nvidia and Microsoft.

AMZN

Read More
2 minute read
  • Earnings
  • Equities
  • General
  • Guidance
  • Large Cap
  • Movers
  • News

Coca-Cola’s Q4 US Demand Takes Hit, Still Expects FY24 Organic Revenue Growth

By Vandana Singh
February 13, 10:20 AM
Coca-Cola's Q4 2023 with $10.8 billion sales, a 7% YoY boost, beating estimates. Organic revenue grows 12%, driven by global volume, while EPS meets expectations.

KO

Read More
2 minute read
  • Earnings
  • Equities
  • General
  • Guidance
  • Movers
  • News

Why Doughnut Maker Krispy Kreme Shares Are Falling Today

By Nabaparna Bhattacharya
February 13, 9:59 AM
Krispy Kreme shares dip premarket as Q4 earnings miss analyst estimates despite solid sales growth; outlook disappoints.

DNUT

Read More
1 minute read
  • Earnings
  • Equities
  • General
  • Guidance
  • Markets
  • Movers
  • News

Why Ed-Tech Company 2U Shares Are Falling Today

By Nabaparna Bhattacharya
February 13, 9:31 AM
Ed-Tech operator 2U, Inc. experiences a significant premarket drop as fourth-quarter earnings miss estimates, with revenue and forecasts falling short of expectations.

TWOU

Posts pagination

Previous 1 … 271 272 273 … 1,061 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service